Royalty Pharma vs Magnus Grimeland

Royalty Pharma vs Magnus Grimeland

Royalty Pharma is a venture capital based in New York, New York, United States. Magnus Grimeland is a accelerator based in New York across 1,800 portfolio companies. Sector focus diverges: Royalty Pharma concentrates on generalist deals and Magnus Grimeland on Artificial Intelligence. On stage, Royalty Pharma is active at undisclosed stages and Magnus Grimeland at Pre Seed.

• Investor type: Royalty Pharma — Venture Capital; Magnus Grimeland — Accelerator
• Headquarters: Royalty Pharma — New York, New York, United States; Magnus Grimeland — New York
• Portfolio companies: Royalty Pharma — not disclosed; Magnus Grimeland — 1,800
• Sectors: Royalty Pharma — not disclosed; Magnus Grimeland — Artificial Intelligence
• Stages: Royalty Pharma — not disclosed; Magnus Grimeland — Pre Seed

• Royalty Pharma — Venture Capital · New York, New York, United States · Royalty Pharma portfolio
• Magnus Grimeland — Accelerator · New York · 1,800 tracked deals · Magnus Grimeland portfolio

Similar investors

• Pal B. Ristvedt
• Opto Custom GP 2023 LLC
• Antler Special Opportunities GP I LLC
• Harsha Marti
• Timothy Huang
• Steven Leischner
• Marc K. Furstein
• Fady Abdel-Nour
• Governors Lane Fund General Partner LLC
• Lexington Partners GP Holdings X, L.L.C.

Investors like Royalty Pharma · Investors like Magnus Grimeland · Royalty Pharma co-investors · Full investor directory